| Acronym |
Full form |
|
|
Acronym: ADHD
|
attention deficit hyperactivity disorder
|
der known as restless leg syndrome or RLS. Some examples of these are ropinirole and pramipexole. Psychological disorders like that of attention deficit hyperactivity disorder (ADHD) can be treated with drugs like methylphenidate (also known as Ritalin) which block the re-uptake of dopamine by the pre-synaptic cell, thereby providing an increase of dopamine left in the sy |
|
Acronym: RLS
|
restless leg syndrome
|
alled periodic limb movements of sleep (PLMS). (Most people who have PLMS do not have a disorder, and do not require any treatment). PLMD should not be confused with restless leg syndrome (RLS). RLS occurs while awake as well as when asleep, and when awake, there is a voluntary response to an uncomfortable feeling in the legs. PLMD on the other hand is involuntary, and the patient is often |
|
Acronym: SSRI
|
selective serotonin reuptake inhibitor
|
el use|off-label]] as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants. Pramipexole has shown robust effects on pilot studies in a placebo-controlled proof of concept study in bipolar disorder. Biol Psychiatry. 2004 Jul 1;56(1):54-60. Pramipexo |
|
Acronym: SSRI
|
selective serotonin reuptake inhibitor
|
el use|off-label]] as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants. Pramipexole has shown robust effects on pilot studies in a placebo-controlled proof of concept study in bipolar disorder. Biol Psychiatry. 2004 Jul 1;56(1):54-60. Pramipexo |
|
Acronym: RLS
|
restless legs syndrome
|
drugs act as dopamine agonists; they are typically used for treating Parkinson's disease and certain pituitary tumors (prolactinoma), and may be useful for restless legs syndrome (RLS). Both Requip (Ropinirole) and Mirapex (Pramipexole) are FDA-approved for the treatment of RLS. There is also an ongoing clinical trial to test the effectiveness of Requip ([[rop |
|
Acronym: RLS
|
restless legs syndrome
|
drugs act as dopamine agonists; they are typically used for treating Parkinson's disease and certain pituitary tumors (prolactinoma), and may be useful for restless legs syndrome (RLS). Both Requip (Ropinirole) and Mirapex (Pramipexole) are FDA-approved for the treatment of RLS. There is also an ongoing clinical trial to test the effectiveness of Requip ([[rop |
|
Acronym: PVD
|
peripheral vascular disease
|
Treatment of dizziness in the elderly. * Treatment of retinal ischemic manifestations. * Adjuvant treatment in intermittent claudication due to peripheral vascular disease (PVD) of the lower limbs (stage 2). * Anhedonia and treatment-resistant depression in unipolar_depression|unipolar and bipolar_depression|bipolar depressives (''off label''). |
|
Acronym: CNS
|
central nervous system
|
of Parkinson's disease (PD) or Parkinsonism. Most of these agents act by either increasing dopamine activity or reducing acetylcholine activity in the central nervous system (CNS). == Examples == * L-DOPA (Levodopa) & Carbidopa: L-DOPA enters the brain and is converted into dopamine; Carbidopa prevents the peripheral synthesis of dopamine from L-DOPA to prevent |
|
Acronym: BDB
|
Benzodioxolylbutanamine
|
mone]] • Amphetamine (Dextroamphetamine, Levoamphetamine) • Amphetaminil • beta-Methylphenethylamine|β-Methylphenethylamine (β-Me-PEA) • Benzodioxolylbutanamine (BDB) • Benzodioxolylhydroxybutanamine (BOH) • Benzphetamine • Buphedrone • Butylone • Cathine • Cathinone • Clobenzorex • Clortermine • D-Deprenyl • |
|
Acronym: DMA
|
Dimethoxyamphetamine
|
namine]] (BOH) • Benzphetamine • Buphedrone • Butylone • Cathine • Cathinone • Clobenzorex • Clortermine • D-Deprenyl • Dimethoxyamphetamine (DMA) • Dimethoxymethamphetamine (DMMA) • Dimethylamphetamine • Dimethylcathinone (Dimethylpropion, Metamfepramone) • Ethcathinone (Ethylpropion) • Ethylamphetamine • [[Ethy |
|
Acronym: EBDB
|
Ethylbenzodioxolylbutanamine
|
(DMMA) • Dimethylamphetamine • Dimethylcathinone (Dimethylpropion, Metamfepramone) • Ethcathinone (Ethylpropion) • Ethylamphetamine • Ethylbenzodioxolylbutanamine (EBDB) • Ethylone • Fenethylline • Fenproporex • Flephedrone • Fludorex • Furfenorex • Hordenine • Indanorex • Lophophine (Homomyristicylamine) • [[Me |
|
Acronym: MMDMA
|
Methoxymethylenedioxymethamphetamine
|
ethamphetamine]], Levomethamphetamine) • Methcathinone (Methylpropion) • Methedrone • Methoxymethylenedioxyamphetamine (MMDA) • Methoxymethylenedioxymethamphetamine (MMDMA) • Methylbenzodioxolylbutanamine (MBDB) • Methylenedioxyamphetamine (MDA; Tenamfetamine) • Methylenedioxyethylamphetamine (MDEA) • Methylenedioxyhydroxyamphetamine (MDOH) • [ |
|
Acronym: MDEA
|
Methylenedioxyethylamphetamine
|
) • Methoxymethylenedioxymethamphetamine (MMDMA) • Methylbenzodioxolylbutanamine (MBDB) • Methylenedioxyamphetamine (MDA; Tenamfetamine) • Methylenedioxyethylamphetamine (MDEA) • Methylenedioxyhydroxyamphetamine (MDOH) • Methylenedioxymethamphetamine (MDMA) • Methylenedioxymethylphenethylamine (MDMPEA; Homarylamine) • Methylenedioxyphenethylamine (MD |
|
Acronym: MDMA
|
Methylenedioxymethamphetamine
|
(MBDB) • Methylenedioxyamphetamine (MDA; Tenamfetamine) • Methylenedioxyethylamphetamine (MDEA) • Methylenedioxyhydroxyamphetamine (MDOH) • Methylenedioxymethamphetamine (MDMA) • Methylenedioxymethylphenethylamine (MDMPEA; Homarylamine) • Methylenedioxyphenethylamine (MDPEA; Homopiperonylamine) • Methylone • Ortetamine • Parabromoamphetamine (P |
|
Acronym: PCA
|
Parachloroamphetamine
|
ne]] (MDMPEA; Homarylamine) • Methylenedioxyphenethylamine (MDPEA; Homopiperonylamine) • Methylone • Ortetamine • Parabromoamphetamine (PBA) • Parachloroamphetamine (PCA) • 4-Fluoroamphetamine|Parafluoroamphetamine (PFA) • 4-Fluoromethamphetamine|Parafluoromethamphetamine (PFMA) • Parahydroxyamphetamine (PHA) • Paraiodoamphetamine (PIA) • [[P |
|
Acronym: PIA
|
Paraiodoamphetamine
|
]] (PCA) • 4-Fluoroamphetamine|Parafluoroamphetamine (PFA) • 4-Fluoromethamphetamine|Parafluoromethamphetamine (PFMA) • Parahydroxyamphetamine (PHA) • Paraiodoamphetamine (PIA) • Paramethoxyamphetamine (PMA) • Paramethoxyethylamphetamine (PMEA) • Paramethoxymethamphetamine (PMMA) • Paredrine (Norpholedrine, Oxamphetamine) • Phenethylamine (PEA) |
|
Acronym: PMEA
|
Paramethoxyethylamphetamine
|
ethamphetamine|Parafluoromethamphetamine]] (PFMA) • Parahydroxyamphetamine (PHA) • Paraiodoamphetamine (PIA) • Paramethoxyamphetamine (PMA) • Paramethoxyethylamphetamine (PMEA) • Paramethoxymethamphetamine (PMMA) • Paredrine (Norpholedrine, Oxamphetamine) • Phenethylamine (PEA) • Pholedrine • Phenpromethamine • Prenylamine • [[Propylamp |
|
Acronym: PEA
|
Phenethylamine
|
• Paramethoxyamphetamine (PMA) • Paramethoxyethylamphetamine (PMEA) • Paramethoxymethamphetamine (PMMA) • Paredrine (Norpholedrine, Oxamphetamine) • Phenethylamine (PEA) • Pholedrine • Phenpromethamine • Prenylamine • Propylamphetamine • Tiflorex (Flutiorex) • Tyramine (TRA) • Xylopropamine • Zylofuramine; ''Piperazines |
|
Acronym: BZP
|
Benzylpiperazine
|
e]] • Tiflorex (Flutiorex) • Tyramine (TRA) • Xylopropamine • Zylofuramine; ''Piperazines'': 2,5-Dimethoxy-4-bromobenzylpiperazine (2C-B-BZP) • Benzylpiperazine (BZP) • Methoxyphenylpiperazine (MeOPP; Paraperazine) • Methylbenzylpiperazine (MBZP) • Methylenedioxybenzylpiperazine (MDBZP; Piperonylpiperazine); ''Others'': [[2-Amino-1,2-dihydronapht |
|
Acronym: IAP
|
Indanylaminopropane
|
P) • Clofenciclan • Cyclopentamine • Cypenamine • Cyprodenate • Feprosidnine • Gilutensin • Heptaminol • Hexacyclonate • Indanylaminopropane (IAP) • Isometheptene • Methylhexanamine • Naphthylaminopropane (NAP) • Octodrine • Phthalimidopropiophenone • Propylhexedrine (PHX) • Tuaminoheptane (Tuamine) |
|
Acronym: PHX
|
Propylhexedrine
|
e]] • Indanylaminopropane (IAP) • Isometheptene • Methylhexanamine • Naphthylaminopropane (NAP) • Octodrine • Phthalimidopropiophenone • Propylhexedrine (PHX) • Tuaminoheptane (Tuamine) | group4 = Enzyme_inhibitor|Enzyme Inhibitors | list4 = {{Navbox subgroup | groupstyle = background-color: LightYellow | group1 = Anabolism |
|
Acronym: PPAP
|
Phenylpropylaminopentane
|
[Ascorbic acid|Ascorbic Acid]]) • Zinc (Zn 2+ ) | group3 = Others | list3 = ''Activity Enhancers'': Benzofuranylpropylaminopentane (BPAP) • Phenylpropylaminopentane (PPAP) }} }}</text> </revision> |